Skip to main content

Find Clinical Trials

Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,647 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Minority AIDS Initiative Retention and Re-Engagement Project

NCT01616940

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Care Resource Miami, Florida, United States

Center for Advancing Health Policy and Practice Boston, Massachusetts, United States

PATH Center, The Brooklyn Hospital Brooklyn, New York, United States

Puerto Rico Community Network for Clinical Research on AIDS San Juan, Puerto Rico

View Trial Details

Completed

Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels

NCT00987948

Conditions: Blood-Borne Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Hawaii Center for AIDS Honolulu, Hawaii, United States

View Trial Details

Completed

Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B

NCT01923610

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Hospital Clínic i Provincial de Barcelona Barcelona, Catalonia, Spain

Hospital Universitario Gregorio Marañón Madrid, Spain

View Trial Details

Completed

A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)

NCT00369941

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)

NCT00293254

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)

NCT01000818

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)

NCT00764946

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247)

NCT01622673

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Vitamin D Supplementation in HIV

NCT01475890

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Early Versus Delayed BCG Vaccination of HIV-exposed Infants

NCT02062580

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: Not specified

View Trial Details